Polpharma Transfers Latin American Rights to Autoimmune Disease Biosimilar, Targets Approval Within 3 Years
Polpharma Biologics has entered into an exclusive licensing agreement with Argentina-based Tuteur for one autoimmune disease biosimilar, marking its entry into the Latin American market. Under the agreement, Polpharma will be responsible for development and manufacturing, while T
2026-05-25


